Mount Sinai to halt gender-affirming treatments for minors, allocates $2 million for detransition care

In a Friday announcement, the Justice Department disclosed that Mount Sinai Health System has entered a settlement requiring the cessation of puberty blockers, cross-sex hormones and gender-affirming surgeries for minors. While the exact cash penalty remains undisclosed, the agreement obligates the hospital to deliver $2 million in free detransition care to patients who allege injury from the procedures. Attorney General Todd Blanche emphasized the Department’s commitment to enforcing federal law and protecting children, describing the settlement as both an end to the practices at Mount Sinai and meaningful relief for victims.

The deal mirrors earlier settlements with Texas Children’s Hospital, Cleveland Clinic Foundation and Connecticut Children’s Hospital, and the Justice Department praised Mount Sinai’s cooperation. The broader investigation, launched under President Donald Trump’s directive, examines possible breaches of the Food, Drug, and Cosmetic Act, the False Claims Act and other health-care statutes, including fraudulent billing. Assistant Attorney General Brett Shumate and U.S. Attorney Ryan Raybould highlighted the ongoing effort to hold providers accountable.